Drug - Giazo [Salix Pharmaceuticals]
January 2018
Therapeutic area - Ulcerative Colitis
204 tablets per 34-day supply
GIAZO is a locally acting aminosalicylate indicated for the treatment of mildly to moderately active ulcerative colitis in male patients 18 years of age and older. Patients taking Giazo are directed to take three 1.1 g tablets 2 times a day for 8 weeks. The generically available balsalazide daily dose is similar to that of Giazo; the only difference is the frequency of administration.
MHCP Provider Call Center 651-431-2700 or 800-366-5411